A Rare Case of Ipilimumab-induced Reversible Hypophysitis and Permanent Primary Hypothyroidism

Ipilimumab is a monoclonal antibody targeting the cytotoxic T-lymphocyte antigen-4 receptor, which was originally approved for the treatment of metastatic melanoma. It is the first immune checkpoint inhibitor to enter clinical practice. Immune toxicity due to ipilimumab causing colitis, hepatitis, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Erra, Amani, Pannu, Bibek Singh, Patel, Sabah, Qureshi, Faisal, Soliman, Mohanad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713251/
https://www.ncbi.nlm.nih.gov/pubmed/31497432
http://dx.doi.org/10.7759/cureus.5001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713251/
https://www.ncbi.nlm.nih.gov/pubmed/31497432
http://dx.doi.org/10.7759/cureus.5001

Ejemplares similares